Short-Term Effect of Vitamin K Administration on Prednisolone-Induced Loss of Bone Mineral Density in Patients with Chronic Glomerulonephritis

[1]  John Adams,et al.  Gains in Bone Mineral Density with Resolution of Vitamin D Intoxication , 1997, Annals of Internal Medicine.

[2]  Y. Koshihara,et al.  Vitamin K2 Enhances Osteocalcin Accumulation in the Extracellular Matrix of Human Osteoblasts In Vitro , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  H. Mulder,et al.  Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis. , 1995, The American journal of medicine.

[4]  S. Barbagallo,et al.  Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women. , 1995, The American journal of medicine.

[5]  G. Gronowicz,et al.  Glucocorticoids inhibit the attachment of osteoblasts to bone extracellular matrix proteins and decrease beta 1-integrin levels. , 1995, Endocrinology.

[6]  Y. Akiyama,et al.  Effects of menatetrenone on prednisolone-induced bone loss in rats. , 1993, Bone.

[7]  J. Eisman,et al.  Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. , 1993, The New England journal of medicine.

[8]  M. Shiraki,et al.  Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  M. Shearer,et al.  Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. , 1991, Bone.

[10]  G. Gronowicz,et al.  Glucocorticoids stimulate resorption in fetal rat parietal bones in vitro , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  J. Tobias,et al.  Glucocorticoids impair bone resorptive activity and viability of osteoclasts disaggregated from neonatal rat long bones. , 1989, Endocrinology.

[12]  W. Franck,et al.  Vitamin D toxicity complicating the treatment of senile, postmenopausal, and glucocorticoid-induced osteoporosis. Four case reports and a critical commentary on the use of vitamin D in these disorders. , 1987, The American journal of medicine.

[13]  L. Klenerman,et al.  Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis. , 1985, The Journal of clinical endocrinology and metabolism.

[14]  S. Teitelbaum,et al.  Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. , 1979, The Journal of clinical investigation.

[15]  L. Raisz,et al.  Effect of glucocorticoids on bone resorption in tissue culture. , 1972, Endocrinology.

[16]  B. Riggs,et al.  Bone formation in hypercortisonism. , 1970, Acta endocrinologica.

[17]  P. Stern.  INHIBITION BY STEROIDS OF PARATHYROID HORMONE-INDUCED $sup 45$Ca RELEASE FROM EMBRYONIC RAT BONE IN VITRO. , 1969 .